What Is It, and Why Does It Matter?
Icotyde (icotrokinra) is a once-daily pill for moderate to severe plaque psoriasis. It is for adults and for those 12 years and older who weigh at least 40 kilograms (about 88 pounds) and need a whole-body treatment or phototherapy. Psoriasis is an immune condition that causes red, scaly patches on the skin. This medicine targets interleukin-23 (IL-23), a protein that drives inflammation. It prevents IL-23 from working by blocking its receptor. What sets this approval apart is the form of treatment.
Icotyde is the first approved oral medicine that targets IL-23 for plaque psoriasis. At this time, there is no other pill in this class. Many systemic treatments for psoriasis are given as shots. Having a pill option may be a treatment option if you prefer not to use needles. The clinical program studied adults and adolescents. It also looked at areas that can be hard to treat, like the scalp and genitals. These sites often affect daily activities and comfort. Seeing benefit in these regions may be especially meaningful for you.
Why Was It Approved?
The approval was based on results from late-stage studies. More people taking Icotyde reached clear or almost clear skin, compared with those on a placebo. It also did better than deucravacitinib, another oral treatment, when the two were compared directly. By week 16, about 70% reached clear or almost clear skin on a common physician rating. Also, about 55% saw major improvement on a widely used severity index. In a separate study against a placebo, the medicine showed strong results. Benefits continued for up to a year, including in adolescents.
Another study focused on areas like the scalp and genitals. People taking Icotyde had meaningful clearing in these high-impact sites. Safety findings were generally favorable. Through week 16, overall side effect rates were close to those of a placebo, within a little over 1%. No new safety concerns were seen through one year. The most common side effects were headaches, nausea, coughing, fatigue, and fungal infections.
What Do I Need to Know?
The recommended dose is 200 mg once daily. Take it when you wake up, with water, on an empty stomach. Wait at least 30 minutes before you eat. If you miss a dose, take it as soon as possible. Then take your next dose at the usual time the next day. If swallowing tablets is hard for you, ask your health care provider about dispersing a tablet in water. They can show you how to do this, so you get the full dose.
Tell your health care provider if you currently have an infection. Do not start this medicine until the infection is treated. Your health care provider may screen you for tuberculosis (TB) before starting. Do not use this medicine if you have active TB. Avoid live vaccines during treatment. Try to get routine vaccines up to date before you begin. Common side effects include headaches, nausea, coughing, fatigue, and fungal infections. If you have kidney problems, your health care provider may monitor you more closely for side effects.
Icotyde adds an oral, whole-body option for moderate to severe plaque psoriasis. It may be a choice if you prefer a pill over shots, or if you need a systemic treatment. Ask your pharmacist about when it may be available and how insurance may cover it. Talk with your health care provider about your other medicines and health issues. Together, you can decide how this treatment may fit your plan.